A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood
Clinical trial NCT04060719 · COMPLETED
Trial details
- NCT number
- NCT04060719
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2019-10-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.